Cost-Utility of Aspirin and Proton Pump Inhibitors for Primary Prevention
Open Access
- 14 February 2011
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of internal medicine (1960)
- Vol. 171 (3) , 218-225
Abstract
The value of aspirin treatment for primary prevention in men depends on trade-offs between its ability to reduce nonfatal myocardial infarction and its potential to increase the risk of hemorrhagic stroke and extracranial (primarily gastrointestinal tract [GI]) bleeding.1 Although the increased risk of hemorrhagic stroke cannot be mitigated, risk of upper GI bleeding can be reduced by acid-suppressive therapy.2,3 A recent model suggests that the addition of generic, low-cost omeprazole to the treatment regimen of patients 65 years or older who are using aspirin for secondary prevention may be cost-effective owing to its impact on reducing serious GI adverse events.4Keywords
This publication has 24 references indexed in Scilit:
- Proton-Pump Inhibitor Use Is Not Associated With Osteoporosis or Accelerated Bone Mineral Density LossGastroenterology, 2010
- Aspirin, Statins, or Both Drugs for the Primary Prevention of Coronary Heart Disease Events in Men: A Cost–Utility AnalysisAnnals of Internal Medicine, 2006
- Aspirin for the Primary Prevention of Cardiovascular Events in Women and MenJAMA, 2006
- A Multi-Country Economic Evaluation of Low-Dose Aspirin in the Primary Prevention of Cardiovascular DiseasePharmacoEconomics, 2006
- Lansoprazole for the Prevention of Recurrences of Ulcer Complications from Long-Term Low-Dose Aspirin UseNew England Journal of Medicine, 2002
- Aspirin for the Primary Prevention of Cardiovascular Events: A Summary of the Evidence for the U.S. Preventive Services Task ForceAnnals of Internal Medicine, 2002
- The natural history of prevalent ischaemic heart disease in middle-aged menEuropean Heart Journal, 2000
- Aspirin and Risk of Hemorrhagic StrokeJAMA, 1998
- Long-term survival after first-ever stroke: the Oxfordshire Community Stroke Project.Stroke, 1993
- Cardiovascular disease risk profilesAmerican Heart Journal, 1991